Category: drug costs

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

Trump Administration Sinks Teeth Into Paring Down Drug Prices, On 5 Key Points

Instead of waiting for congressional action, federal regulators are looking at a series of actions to spur competition and drive down the cost of medicines.

Podcast: KHN’s ‘What The Health?’ Coming Soon: ‘Long-Term Short-Term’ Plans

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Margot Sanger-Katz of The New York Times and Kimberly Leonard of the Washington Examiner talk about the latest Trump administration efforts to address high drug prices, what’s next for short-term health insurance plans and insider trading charges against a New York GOP congressman.

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

Pharmacy-Made Pain Creams Flagged On Fears Of Medicare Fraud And Risk

Inspector general identifies possible problems in nearly 23 percent of pharmacies that bill Medicare for blended creams, gels and lotions.

Medicaid Expansion Making Diabetes Meds More Accessible To Poor, Study Shows

The number of diabetes drug prescriptions filled for low-income people enrolled in Medicaid rose sharply in states that expanded eligibility for the program under the Affordable Care Act, according to a new study.

To Tame Prescription Prices, HHS Dips A Toe Into Drug Importation Stream

The Trump administration signals it is willing to consider such a move if it is carefully tailored to focus solely on specific situations where a high-priced drug is made by one company.

Podcast: KHN’s ‘What The Health?’ Congress And Health Care. Again.

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Anna Edney of Bloomberg News, Alice Ollstein of Talking Points Memo and Kimberly Leonard of the Washington Examiner talk about the new push on health legislation by Republicans in the House, as well as developments on Medicaid work requirements, drug prices and the fate of children separated from their parents at the U.S.-Mexican border. Plus, for extra credit, the panelists offer their favorite health stories of the week.

Podcast: KHN’s ‘What The Health?’ Drug Prices And Unicorns

In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of STAT News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.

Staggering Prices Slow Insurers’ Coverage Of CAR-T Cancer Therapy

Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.